The TruSeq Stranded mRNA and Total RNA Sample Preparation Kits are the newest additions to the TruSeq line of sample prep solutions, which are designed to further advance data quality, ease-of-use, and the cost effectiveness of sequencing. Additional benefits of TruSeq Stranded mRNA and Total RNA Sample Preparation Kits include:
- An improved workflow, requiring less hands-on time while delivering the same high standard of performance and affordability as Illumina’s current TruSeq products.
- High strand specificity and uniform coverage in a comprehensive end-to-end solution.
- Availability in multiple configurations, including 48-sample low-throughput kits containing 12 of 24 total available indexes, and 96-sample high-throughput kits. Additionally, the company recently introduced TruSeq DNA HT Sample Preparation Kits, which contain 96 unique index pairs pre-loaded into 96-well plates.
TruSeq Stranded mRNA and Total RNA Sample Preparation Kits are now shipping. For more information, visit www.illumina.com/RNA.
Illumina ( www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.Forward-Looking Statements This release may contain forward looking statements that involve risks and uncertainties. Important factors that could cause actual results to differ materially from those in any forward-looking statements are detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We do not intend to update any forward-looking statements after the date of this release.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts